Vertex Pharmaceuticals (VRTX) Change in Intangibles (2023 - 2024)
Vertex Pharmaceuticals (VRTX) posted quarterly Change in Intangibles of $375.4 million for Q4 2024, up 547.24% year-over-year from $58.0 million in Q1 2024, and up 4975.32% quarter-over-quarter from -$7.7 million in Q2 2024.
Vertex Pharmaceuticals (VRTX) Change in Intangibles (2023 - 2024) Analysis & Trends
Vertex Pharmaceuticals' Change in Intangibles history runs 2 years deep, the most recent figure standing at $375.4 million for Q4 2024.
- In Q4 2024, Change in Intangibles rose 547.24% year-over-year to $375.4 million; the TTM figure through Sep 2025 stood at $375.4 million (up 389.44% YoY), while the FY2024 annual figure was $187.7 million, up 223.62% from the prior year.
- Change in Intangibles for Q4 2024 stood at $375.4 million, up from -$7.7 million in the prior quarter.
- The five-year high for Change in Intangibles was $375.4 million in Q4 2024, with the low at -$180.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 375.40 Mn |
| Dec 31, 2024 | 375.40 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Jun 30, 2024 | -7.70 Mn |
| Mar 31, 2024 | -180.00 Mn |
| Mar 31, 2024 | -180.00 Mn |
| Dec 31, 2023 | 58.00 Mn |
| Dec 31, 2023 | 58.00 Mn |